Global Ocular Drug Delivery Market Growth 2022-2028

Global Ocular Drug Delivery Market Growth 2022-2028

Product Code:214775

Published Date: Jan 13,2022

Pages: 105

Region: Global

Category: Pharma & Healthcare

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

As the global economy mends, the 2021 growth of Ocular Drug Delivery will have significant change from previous year. According to our (LP Information) latest study, the global Ocular Drug Delivery market size is USD  million in 2022 from USD 24130 million in 2021, with a change of % between 2021 and 2022. The global Ocular Drug Delivery market size will reach USD 33910 million in 2028, growing at a CAGR of 5.0% over the analysis period.

The United States Ocular Drug Delivery market is expected at value of US$  million in 2021 and grow at approximately  % CAGR during review period. China constitutes a  % market for the global Ocular Drug Delivery market, reaching US$  million by the year 2028. As for the Europe Ocular Drug Delivery landscape, Germany is projected to reach US$  million by 2028 trailing a CAGR of  % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at  % and  % respectively for the next 5-year period.

Global main Ocular Drug Delivery players cover OCULAR THERAPEUTIX, INC, Alimera Sciences, Allergan, Plc, and EyeGate Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly  % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Ocular Drug Delivery market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
    Ocular Insert
    Iontophoresis
    Intraocular Implants
    In Situ Gel & Punctal Plugs
    Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
    Hospitals
    Ambulatory Surgical Centers
    Ophthalmic Clinics
    Homecare Settings

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
    OCULAR THERAPEUTIX, INC
    Alimera Sciences
    Allergan, Plc
    EyeGate Pharma
    Valeant Pharmaceuticals International, Inc
    Envisia Therapeutics
    Clearside Biomedical
    Graybug Vision Inc
    Taiwan Liposome Company
    Santen Pharmaceutical